<DOC>
	<DOCNO>NCT00453414</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness iloprost PAH child age 3 18 year old .</brief_summary>
	<brief_title>Safety Efficacy Inhaled Iloprost Pediatric Patients With Pulmonary Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>Male female , age 318 year Diagnosis PAH due IPAH , connective tissue disease , congenital heart disease Pulmonary arterial hypertension confirm cardiac catheterization , mPAP &gt; 25 mmHg rest , PCWP LVEDP ≤ 15 mmHg , PVR ≥ 240 dynes/sec/cm5 ( ie , ≥ 3.0 unit m2 ) NYHA/WHO functional Class II , III , IV Have 6minute walk test ( 6MWT ) perform within 3 month precede screen visit ( ≥ 8 year age ) Have cardiopulmonary exercise testing ( CPET ) perform within 3 month precede screen visit ( ≥ 8 year age &gt; 130 cm height . CPET test conduct NYHA/WHO Class IV patient discretion Principal Investigator ) If receive therapy PAH , stable dose regimen least 3 month prior screen visit If receive digoxin , diuretic , oxygen therapy , stable dose regimen least 30 day precede screen visit Must demonstrate ability appropriately use nebulizer device part screen process Prior use prostacyclins prostacyclin analogue within 3 month prior screen Portal hypertension clinically relevant hepatic disease Eisenmenger syndrome rest SpO2 &lt; 88 % room air Clinically relevant asthma chronic lung disease , bronchopulmonary dysplasia , cystic fibrosis , repair unrepaired congenital diaphragmatic hernia Diagnosis current evidence active lung infection clinically relevant hemoptysis Leftsided heart disease , include valvular disease heart failure Initiation dosage adjustment PAHspecific therapy within 3 month prior screen Initiation treatment digoxin , diuretic , anticoagulation , oxygen therapy within 30 day prior screen</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>PAH</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Pulmonary Arterial Hypertension</keyword>
</DOC>